Cold Pain Therapy Market Size, Share, Development, Growth and Demand Forecast to 2028

 

Cold Pain Therapy Market

With the help of the body's endorphins and natural anti-inflammatory response, which are activated by cold therapy, cryotherapy, swelling, inflammation, and pain are reduced. It also contributes to lowering nerve activity, which lessens pain. Patients who suffer from muscle sprains, arthritis, and back pain frequently use ice packs and wraps. Joints and tendons benefit the most from it. There are products for the shoulders, feet, ankles, knees, and other upper extremities. For example, Ossur's Cold Rush Compact has a single flow design and can be used easily to deliver cold therapy both at home and in healthcare settings. Static compression is used in the treatment of another Breg product called Intelli-Flo.

Acute soft tissue injuries are treated with cold pain therapy, which uses the therapeutic properties of cold to treat benign and malignant lesions, treat post-operative pain following orthopaedic surgery, and manage pain. The application of cryotherapy can be done surgically, percutaneously, or topically (on the skin's surface). Various skin conditions like oral mucositis, tumours in the liver, kidney, bones, breasts, and lungs, skin tumours, skin tags, precancerous skin moles, and injuries can also be treated with this.

In the cryosurgery procedure, abnormal tissues are destroyed by using extremely cold temperatures created with the help of liquid nitrogen (or argon gas). The National Cancer Institute (NCI) states that cryosurgery is used to treat a variety of cancers as well as a few non-cancerous conditions. According to reports, it is useful for treating retinoblastoma, actinic keratosis, and cervical intraepithelial neoplasia as well as early-stage skin cancer. In October 2017, a study that was later reported in the Journal of the National Cancer Institute found that cryotherapy was successful in reducing the side effects of chemotherapy-induced peripheral neuropathy.

The main factors propelling the Cold Pain Therapy Market are rising rates of sport and accidental injuries as well as rising prevalence of cancers like skin, prostate, retinoblastoma, and cervical. For instance, the Centers for Disease Control and Prevention (CDC) reports that in 2014, 12,578 women in the United States received a diagnosis of cervical cancer, and 4,115 of those women passed away from the disease. Additionally, 3,224 new cases of cervical cancer were reported in the U.K. alone in 2014, according to Cancer Research UK.

Various Spray Types of Cold Pain Therapy-

·        Spray cryogun

·        Dipstick applicator

·        Cryoprobe

According to the American Academy of Orthopedic Surgeons, 90% of rheumatoid arthritis patients eventually experience foot and ankle symptoms. Additionally, almost one-third of all injuries suffered by kids are sports-related, according to Stanford Children's Health. The demand for cold pain therapy is increasing as a result of the aforementioned factors. Another factor driving the market is an increase in the elderly population. Due to their high risk of developing joint problems like arthritis, this population is expected to see an increase in the demand for products that use cold therapy. Moreover, another significant factor driving the growth of the Cold Pain Therapy Market is the rise in the number of traumatic injuries brought on by slips, trips, and falls as well as accidents on the road.

Major Companies involved are- CryoConcepts LP, Metrum Cryoflex, Brymill Cryogenic Systems, Mectronic Mediccale S.r.l., Sanarus, Wallach Surgical Devices, Zimmer MedizinSystems, CooperSurgical Inc., CSA Medical, Inc., Cortex Technology, Erbe Elektromedizin, GmbH, Special Medical Technology Co., Ltd, Medtronic plc, Galil Medical, Inc., and PHYSIOMED AG.

Comments

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Ginseng Market Outlook, Analysis and forecast up to 2028

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19